BCL2 and neoplasm: Ginsenoside Rg3 in combination with TAE has been shown to significantly decrease CD31, VEGF expression, and levels of the anti-apoptotic Bcl-2 at both mRNA and protein levels, while significantly increasing pro-apoptotic gene caspase-3 and Bax expression in VX2 rabbit tumor models [119].